  
       
      
        
          | Patient data (#0000356) | 
         
          | Disease | 
          - |  
        
          | Reference | 
          United States:Salt Lake City |  
        
          | Template | 
          DNA |  
        
          | Technique | 
          SEQ |  
        
          | Remarks | 
          - |  
        
          | # Reported | 
          1 |  
        
          | Submitter | 
          Sean V. Tavtigian |   
       
      
        
          | Variant data | 
         
          | Allele | 
          Unknown |  
        
          | Reported pathogenicity | 
          Unknown |  
        
          | Concluded pathogenicity | 
          Unknown |  
        
          | Exon | 
          2 |  
        
          | DNA change | 
          c.3G>A |  
        
          | BIC DNA change | 
          231G>A |  
        
          | Protein change | 
          p.M1I |  
        
          | Posterior P | 
          0.981 |  
        
          | IARC Class | 
          4 - Likely pathogenic |  
        
          | Key Observational Reference | 
          Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. |  
        
          | Prior P reference | 
          Vallee MP et al., Human Mutation 37: 627-639, 2016 |  
        
          | Missense analysis Prior P | 
          - |  
        
          | Splicing prior P | 
          0.02 |  
        
          | Other Prior P | 
          0.00 |  
        
          | Combined prior P | 
          0.96 |  
        
          | Segregation LR | 
          2.0 |  
        
          | Pathology LR | 
          - |  
        
          | Sum Family LR | 
          - |  
        
          | Co-occurrence LR | 
          1.07 |  
        
          | case-control LR | 
          - |  
        
          | Product of LRs | 
          2.14 |  
        
          | Comments | 
          Translation initiation methionine site |   
       
      
       
     |